Menu
Back to Journals » Drug Design, Development and Therapy » Volume 9
Review
Siltuximab (CNTO 328): a promising option for human malignancies
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 22,230 | Dovepress* | 18,728+ | 1,787 | 20,515 | |
| PubMed Central* | 3,502 | 551 | 4,053 | ||
| Totals | 22,230 | 2,338 | 24,568 | ||
|
*Since 2 July 2015 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 5 | 0 | 0 | 0 | 1 | 4 |
View citations on PubMed Central and Google Scholar